627 related articles for article (PubMed ID: 28289035)
41. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Okamoto K; Gotoh N; Nishino T
Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
[TBL] [Abstract][Full Text] [Related]
42. Intrinsic Antibacterial Activity of Xeruborbactam
Sun D; Tsivkovski R; Pogliano J; Tsunemoto H; Nelson K; Rubio-Aparicio D; Lomovskaya O
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0087922. PubMed ID: 36102663
[TBL] [Abstract][Full Text] [Related]
43.
Lomovskaya O; Rubio-Aparicio D; Nelson K; Sun D; Tsivkovski R; Castanheira M; Lindley J; Loutit J; Dudley M
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782010
[TBL] [Abstract][Full Text] [Related]
44. Identification of Mutations in the
Ranjitkar S; Reck F; Ke X; Zhu Q; McEnroe G; Lopez SL; Dean CR
mSphere; 2019 Jul; 4(4):. PubMed ID: 31270174
[TBL] [Abstract][Full Text] [Related]
45. Molecular Basis of AmpC β-Lactamase Induction by Avibactam in
López-Argüello S; Montaner M; Oliver A; Moya B
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802668
[TBL] [Abstract][Full Text] [Related]
46. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
[TBL] [Abstract][Full Text] [Related]
47. Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria.
Asli A; Brouillette E; Krause KM; Nichols WW; Malouin F
Antimicrob Agents Chemother; 2016 Feb; 60(2):752-6. PubMed ID: 26574008
[TBL] [Abstract][Full Text] [Related]
48. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo activities of the diazabicyclooctane OP0595 against AmpC-derepressed Pseudomonas aeruginosa.
Morinaka A; Tsutsumi Y; Yamada K; Takayama Y; Sakakibara S; Takata T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Tsujii N; Ida T
J Antibiot (Tokyo); 2017 Mar; 70(3):246-250. PubMed ID: 27999441
[TBL] [Abstract][Full Text] [Related]
50. Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.
Albiero J; Mazucheli J; Barros JPDR; Szczerepa MMDA; Nishiyama SAB; Carrara-Marroni FE; Sy S; Fidler M; Sy SKB; Tognim MCB
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910903
[TBL] [Abstract][Full Text] [Related]
51. Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing
Egge SL; Lewis JS; Hakki M
Antimicrob Agents Chemother; 2023 Aug; 67(8):e0066323. PubMed ID: 37395652
[TBL] [Abstract][Full Text] [Related]
52.
Almarzoky Abuhussain SS; Avery LM; Abdelraouf K; Nicolau DP
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373797
[TBL] [Abstract][Full Text] [Related]
53. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
54. Comparative in vivo activity of human-simulated plasma and epithelial lining fluid exposures of WCK 5222 (cefepime/zidebactam) against KPC- and OXA-48-like-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model.
Lasko MJ; Abdelraouf K; Nicolau DP
J Antimicrob Chemother; 2021 Aug; 76(9):2310-2316. PubMed ID: 34096601
[TBL] [Abstract][Full Text] [Related]
55. Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.
Moya B; Zamorano L; Juan C; Pérez JL; Ge Y; Oliver A
Antimicrob Agents Chemother; 2010 Mar; 54(3):1213-7. PubMed ID: 20086158
[TBL] [Abstract][Full Text] [Related]
56. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli.
Page MG; Dantier C; Desarbre E
Antimicrob Agents Chemother; 2010 Jun; 54(6):2291-302. PubMed ID: 20308379
[TBL] [Abstract][Full Text] [Related]
57. Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study.
Juan C; Conejo MC; Tormo N; Gimeno C; Pascual Á; Oliver A
J Antimicrob Chemother; 2013 Mar; 68(3):619-30. PubMed ID: 23143898
[TBL] [Abstract][Full Text] [Related]
58. Assessment of the
Avery LM; Abdelraouf K; Nicolau DP
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181365
[TBL] [Abstract][Full Text] [Related]
59. Activity of ertapenem/zidebactam (WCK 6777) against problem Enterobacterales.
Mushtaq S; Garello P; Vickers A; Woodford N; Livermore DM
J Antimicrob Chemother; 2022 Sep; 77(10):2772-2778. PubMed ID: 35972407
[TBL] [Abstract][Full Text] [Related]
60. In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.
Li H; Estabrook M; Jacoby GA; Nichols WW; Testa RT; Bush K
Antimicrob Agents Chemother; 2015 Mar; 59(3):1789-93. PubMed ID: 25534728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
